vs
NATURES SUNSHINE PRODUCTS INC（NATR）とRESOURCES CONNECTION, INC.（RGP）の財務データ比較。上の社名をクリックして会社を切り替えられます
NATURES SUNSHINE PRODUCTS INCの直近四半期売上が大きい（$123.8M vs $117.7M、RESOURCES CONNECTION, INC.の約1.1倍）。NATURES SUNSHINE PRODUCTS INCの純利益率が高く（3.3% vs -10.8%、差は14.1%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs -19.2%）。RESOURCES CONNECTION, INC.の直近四半期フリーキャッシュフローが多い（$15.6M vs $7.6M）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs -11.8%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
RGPは旧名Resources Global Professionalsで、Resources Connection, Inc.の事業運営主体です。財務会計、情報管理、ガバナンス・リスク・コンプライアンス、人的資本、法務・規制対応、企業アドバイザリー・リストラクチャリング、戦略コミュニケーション、サプライチェーン管理など多岐にわたる分野でコンサルティングサービスを提供しています。
NATR vs RGP — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $117.7M |
| 純利益 | $4.1M | $-12.7M |
| 粗利率 | 72.5% | 37.1% |
| 営業利益率 | 4.3% | -10.3% |
| 純利益率 | 3.3% | -10.8% |
| 売上前年比 | 4.7% | -19.2% |
| 純利益前年比 | 1379.4% | 81.6% |
| EPS（希薄化後） | $0.23 | $-0.38 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $123.8M | $117.7M | ||
| Q3 25 | $128.3M | $120.2M | ||
| Q2 25 | $114.8M | $139.3M | ||
| Q1 25 | $113.2M | $129.4M | ||
| Q4 24 | $118.2M | $145.6M | ||
| Q3 24 | $114.6M | $136.9M | ||
| Q2 24 | $110.6M | $148.2M | ||
| Q1 24 | $111.0M | $151.3M |
| Q4 25 | $4.1M | $-12.7M | ||
| Q3 25 | $5.3M | $-2.4M | ||
| Q2 25 | $5.3M | $-73.3M | ||
| Q1 25 | $4.7M | $-44.1M | ||
| Q4 24 | $-321.0K | $-68.7M | ||
| Q3 24 | $4.3M | $-5.7M | ||
| Q2 24 | $1.3M | $10.5M | ||
| Q1 24 | $2.3M | $2.5M |
| Q4 25 | 72.5% | 37.1% | ||
| Q3 25 | 73.3% | 39.5% | ||
| Q2 25 | 71.7% | 40.2% | ||
| Q1 25 | 72.1% | 35.1% | ||
| Q4 24 | 72.0% | 38.5% | ||
| Q3 24 | 71.3% | 36.5% | ||
| Q2 24 | 71.4% | 40.2% | ||
| Q1 24 | 71.2% | 37.0% |
| Q4 25 | 4.3% | -10.3% | ||
| Q3 25 | 7.0% | -1.7% | ||
| Q2 25 | 3.7% | -47.0% | ||
| Q1 25 | 5.4% | -38.4% | ||
| Q4 24 | 3.8% | -52.7% | ||
| Q3 24 | 4.6% | -3.5% | ||
| Q2 24 | 5.1% | 7.6% | ||
| Q1 24 | 4.2% | 2.8% |
| Q4 25 | 3.3% | -10.8% | ||
| Q3 25 | 4.2% | -2.0% | ||
| Q2 25 | 4.6% | -52.6% | ||
| Q1 25 | 4.2% | -34.0% | ||
| Q4 24 | -0.3% | -47.2% | ||
| Q3 24 | 3.8% | -4.2% | ||
| Q2 24 | 1.2% | 7.1% | ||
| Q1 24 | 2.1% | 1.7% |
| Q4 25 | $0.23 | $-0.38 | ||
| Q3 25 | $0.30 | $-0.07 | ||
| Q2 25 | $0.28 | $-2.21 | ||
| Q1 25 | $0.25 | $-1.34 | ||
| Q4 24 | $-0.02 | $-2.08 | ||
| Q3 24 | $0.23 | $-0.17 | ||
| Q2 24 | $0.07 | $0.31 | ||
| Q1 24 | $0.12 | $0.08 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $89.8M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $161.6M | $194.6M |
| 総資産 | $261.1M | $289.3M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $93.9M | $89.8M | ||
| Q3 25 | $95.6M | $77.5M | ||
| Q2 25 | $81.3M | $86.1M | ||
| Q1 25 | $86.5M | $72.5M | ||
| Q4 24 | $84.7M | $78.2M | ||
| Q3 24 | $78.7M | $89.6M | ||
| Q2 24 | $68.7M | $108.9M | ||
| Q1 24 | $77.8M | $113.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $194.6M | ||
| Q3 25 | $166.7M | $206.4M | ||
| Q2 25 | $163.7M | $207.1M | ||
| Q1 25 | $167.1M | $277.8M | ||
| Q4 24 | $161.0M | $325.7M | ||
| Q3 24 | $162.6M | $407.2M | ||
| Q2 24 | $156.4M | $418.8M | ||
| Q1 24 | $159.7M | $414.9M |
| Q4 25 | $261.1M | $289.3M | ||
| Q3 25 | $264.8M | $287.2M | ||
| Q2 25 | $254.9M | $304.7M | ||
| Q1 25 | $252.7M | $375.6M | ||
| Q4 24 | $240.9M | $424.9M | ||
| Q3 24 | $245.3M | $512.9M | ||
| Q2 24 | $235.8M | $510.9M | ||
| Q1 24 | $247.3M | $523.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $15.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | $15.6M |
| FCFマージンFCF / 売上 | 6.1% | 13.2% |
| 設備投資強度設備投資 / 売上 | 1.9% | 0.3% |
| キャッシュ転換率営業CF / 純利益 | 2.41× | — |
| 直近12ヶ月FCF直近4四半期 | $28.8M | $24.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $9.9M | $15.9M | ||
| Q3 25 | $18.5M | $-7.8M | ||
| Q2 25 | $4.3M | $16.8M | ||
| Q1 25 | $2.6M | $659.0K | ||
| Q4 24 | $12.2M | $1.8M | ||
| Q3 24 | $9.6M | $-309.0K | ||
| Q2 24 | $1.3M | $3.2M | ||
| Q1 24 | $2.2M | $20.5M |
| Q4 25 | $7.6M | $15.6M | ||
| Q3 25 | $16.8M | $-8.0M | ||
| Q2 25 | $3.0M | $16.5M | ||
| Q1 25 | $1.5M | $238.0K | ||
| Q4 24 | $10.0M | $61.0K | ||
| Q3 24 | $7.9M | $-575.0K | ||
| Q2 24 | $-2.0M | $3.0M | ||
| Q1 24 | $-1.5M | $20.4M |
| Q4 25 | 6.1% | 13.2% | ||
| Q3 25 | 13.1% | -6.6% | ||
| Q2 25 | 2.6% | 11.8% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 8.5% | 0.0% | ||
| Q3 24 | 6.9% | -0.4% | ||
| Q2 24 | -1.9% | 2.1% | ||
| Q1 24 | -1.4% | 13.5% |
| Q4 25 | 1.9% | 0.3% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.2% | 0.2% | ||
| Q1 25 | 1.0% | 0.3% | ||
| Q4 24 | 1.9% | 1.2% | ||
| Q3 24 | 1.5% | 0.2% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 0.1% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | 0.30× | ||
| Q1 24 | 0.94× | 8.04× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
